Pertuzumab plus trastuzumab plus docetaxel for metastatic breast …
https://pubmed.ncbi.nlm.nih.gov/22149875/
Jan 12, 2012 · Background: The anti-human epidermal growth factor receptor 2 (HER2) humanized monoclonal antibody trastuzumab improves the outcome in patients with HER2-positive metastatic breast cancer. However, most cases of advanced disease eventually progress. Pertuzumab, an anti-HER2 humanized monoclonal antibody that inhibits receptor dimerization, …
DA: 53 PA: 56 MOZ Rank: 83